PharmaShell®

Controlled Release for Simpler Treatment

PharmaShell® is Nanexa’s proprietary drug delivery platform for long-acting injectable medicines. The platform is based on Atomic Layer Deposition (ALD), in which particles of active pharmaceutical ingredient are coated with an ultra-thin and dense inorganic shell. By tailoring the composition and thickness of the coating, we can achieve a controlled drug release from our products.

Following injection, the coated particles form a depot at the injection site. As the coating gradually dissolves, the active pharmaceutical ingredient is released in a controlled manner. PharmaShell® can therefore enable longer dosing intervals and more stable drug exposure. Fewer administration occasions may simplify treatment, reduce treatment burden and improve the conditions for patient adherence.

What is PharmaShell®?

Learn more about the ALD-based technology, how it works and how the release profile can be tailored.

Learn more

What are the benefits?

Discover how controlled release, high active pharmaceutical ingredient loading and broad applicability can create value for patients, healthcare providers and pharmaceutical partners.

Learn more